ACE2 News and Research

RSS
How SARS-CoV-2's spike protein highjacks the host cell trafficking machinery

How SARS-CoV-2's spike protein highjacks the host cell trafficking machinery

Scientists explain why some COVID-19 patients develop neurological symptoms

Scientists explain why some COVID-19 patients develop neurological symptoms

Why blood type O might lower risk for SARS-CoV-2 infection

Why blood type O might lower risk for SARS-CoV-2 infection

Integrin b3 and ACE2 linked by short linear motifs enabling endocytosis and autophagy of SARS-CoV-2

Integrin b3 and ACE2 linked by short linear motifs enabling endocytosis and autophagy of SARS-CoV-2

COVID-19 survivors may have protective antibodies for 4 months

COVID-19 survivors may have protective antibodies for 4 months

Elevated plasma ACE2 activity persists months after SARS-CoV-2 infection

Elevated plasma ACE2 activity persists months after SARS-CoV-2 infection

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

Analysis of existing comorbidities and COVID-19 mortality

Analysis of existing comorbidities and COVID-19 mortality

Neutralizing responses to infection relatively common in COVID-19

Neutralizing responses to infection relatively common in COVID-19

Researchers identify a promising method to stop COVID-19 infection

Researchers identify a promising method to stop COVID-19 infection

Study: New viral mutations would not impact the efficacy of Covid-19 vaccine candidates

Study: New viral mutations would not impact the efficacy of Covid-19 vaccine candidates

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

SARS-CoV-2 spike protein may induce analgesia

SARS-CoV-2 spike protein may induce analgesia

New clinical report on brain changes in deceased COVID-19 patients

New clinical report on brain changes in deceased COVID-19 patients

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

Chronic illnesses promote active SARS-CoV-2 infection via suppressed mucosal immunity

Cats and dogs are low risk for SARS-CoV-2 transmission to humans

Cats and dogs are low risk for SARS-CoV-2 transmission to humans

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Production of six monoclonal antibodies against SARS-CoV-2 spike protein